000 | 01827 a2200493 4500 | ||
---|---|---|---|
005 | 20250513144327.0 | ||
264 | 0 | _c19980824 | |
008 | 199808s 0 0 eng d | ||
022 | _a0315-162X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorisset, S | |
245 | 0 | 0 |
_aRegulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cJun 1998 |
||
300 |
_a1146-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Northern |
650 | 0 | 4 |
_aCartilage, Articular _xcytology |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aChondrocytes _xdrug effects |
650 | 0 | 4 | _aCyclooxygenase 1 |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aCytokines _xpharmacology |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 |
_aDinoprostone _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEstradiol _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
650 | 0 | 4 |
_aIsoenzymes _xgenetics |
650 | 0 | 4 |
_aNitrobenzenes _xpharmacology |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
700 | 1 | _aPatry, C | |
700 | 1 | _aLora, M | |
700 | 1 | _ade Brum-Fernandes, A J | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 25 _gno. 6 _gp. 1146-53 |
|
999 |
_c9598411 _d9598411 |